Literature DB >> 34724529

Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.

Diana Zhong1, Shaoming Xiao1, Amanda K Debes2, Emily R Egbert1, Patrizio Caturegli1, Elizabeth Colantuoni2, Aaron M Milstone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34724529      PMCID： PMC8561429          DOI： 10.1001/jama.2021.19996

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  32 in total

1.  Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project.

Authors:  Giulia Collatuzzo; Giovanni Visci; Francesco S Violante; Stefano Porru; Gianluca Spiteri; Maria Grazia Lourdes Monaco; Francesca Larese Fillon; Corrado Negro; Christian Janke; Noemi Castelletti; Giuseppe De Palma; Emanuele Sansone; Dana Mates; Silvia Teodorescu; Eleonóra Fabiánová; Jana Bérešová; Luigi Vimercati; Silvio Tafuri; Mahsa Abedini; Giorgia Ditano; Shuffield S Asafo; Paolo Boffetta
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

2.  Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.

Authors:  Damien R Ashby; Ben Caplin; Richard W Corbett; Elham Asgari; Nicola Kumar; Alexander Sarnowski; Richard Hull; David Makanjuola; Nicholas Cole; Jian Chen; Sofia Nyberg; Kieran McCafferty; Faryal Zaman; Hugh Cairns; Claire Sharpe; Kate Bramham; Reza Motallebzadeh; Kashif Jamil Anwari; Alan D Salama; Debasish Banerjee
Journal:  Clin J Am Soc Nephrol       Date:  2022-06       Impact factor: 10.614

3.  Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?

Authors:  Masaaki Takeuchi; Akina Esaki; Yukie Higa; Akemi Nakazono
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

4.  SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.

Authors:  A Sarah Walker; David W Eyre; Koen B Pouwels; Jia Wei; Philippa C Matthews; Nicole Stoesser; Ian Diamond; Ruth Studley; Emma Rourke; Duncan Cook; John I Bell; John N Newton; Jeremy Farrar; Alison Howarth; Brian D Marsden; Sarah Hoosdally; E Yvonne Jones; David I Stuart; Derrick W Crook; Tim E A Peto
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

5.  Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.

Authors:  Joana Oliveira-Silva; Teresa Reis; Cristiana Lopes; Ricardo Batista-Silva; Ricardo Ribeiro; Gilberto Marques; Vania Pacheco; Tiago Rodrigues; Alexandre Afonso; Vítor Pinheiro; Lucília Araújo; Fernando Rodrigues; Isabel Antunes
Journal:  Int J Infect Dis       Date:  2022-05-11       Impact factor: 12.074

6.  Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection.

Authors:  Blanka Wolszczak-Biedrzycka; Anna Bieńkowska; Justyna Dorf
Journal:  Vaccines (Basel)       Date:  2021-12-20

7.  SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021.

Authors:  Thu Nguyen-Anh Tran; Nathan B Wikle; Fuhan Yang; Haider Inam; Scott Leighow; Bethany Gentilesco; Philip Chan; Emmy Albert; Emily R Strong; Justin R Pritchard; William P Hanage; Ephraim M Hanks; Forrest W Crawford; Maciej F Boni
Journal:  medRxiv       Date:  2021-12-07

8.  Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs.

Authors:  Tafadzwa Dzinamarira; Nigel Tungwarara; Itai Chitungo; Munashe Chimene; Patrick Gad Iradukunda; Moreblessing Mashora; Grant Murewanhema; Gallican Nshogoza Rwibasira; Godfrey Musuka
Journal:  Vaccines (Basel)       Date:  2022-02-07

9.  Comparison of total and neutralizing SARS-CoV-2 spike antibodies against omicron and other variants in paired samples after two or three doses of mRNA vaccine.

Authors:  Amanda K Debes; Shaoming Xiao; Emily R Egbert; Patrizio Caturegli; Ioannis Sitaras; Andrew Pekosz; Aaron M Milstone
Journal:  medRxiv       Date:  2022-01-31

10.  Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination.

Authors:  Angelos Hatzakis; Andreas Karabinis; Sotirios Roussos; Nikos Pantazis; Dimitrios Degiannis; Antigoni Chaidaroglou; Konstantinos Petsios; Ioanna Pavlopoulou; Sotirios Tsiodras; Dimitrios Paraskevis; Vana Sypsa; Mina Psichogiou
Journal:  Vaccines (Basel)       Date:  2022-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.